Showing results (1-10 of 150) with videos related to
Sort By:
Pageof 15
Aging Clinical and Experimental Research|February 7, 2020
The contribution of CNVs to the most common aging-related neurodegenerative diseasesGiulia Gentile, Valentina La Cognata, Sebastiano CavallaroCells|January 16, 2020
Splicing Players Are Differently Expressed in Sporadic Amyotrophic Lateral Sclerosis Molecular Clusters and Brain RegionsValentina La Cognata, Giulia Gentile, Eleonora Aronica, et al.Frontiers in Pharmacology|December 15, 2016
Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type DevelopmentGiulia Gentile, Manuela Ceccarelli, Laura Micheli, et al.International Journal of Molecular Sciences|October 16, 2025
Artificial Intelligence-Driven Multi-Omics Approaches in GlioblastomaGiovanna Morello, Valentina La Cognata, Maria Guarnaccia, et al.Expert Opinion on Therapeutic Targets|May 29, 2026
RNA-centric approaches in amyotrophic lateral sclerosis: prospects for future therapeuticsValentina La Cognata, Giulia Gentile, Giovanna Morello, et al.Journal of Personalized Medicine|April 27, 2026
Artificial Intelligence in Transcriptomics: From Human-in-the-Loop to Agentic AIGiulia Gentile, Giovanna Morello, Valentina La Cognata, et al.Experimental Neurology|June 7, 2025
Predicting amyotrophic lateral sclerosis in the pre-symptomatic phase: Insights from SOD1G93A mouse gene expression profilesValentina La Cognata, Maria Guarnaccia, Giovanna Morello, et al.Annals of Clinical and Translational Neurology|November 18, 2025
Multi-Omics Integration for Advancing Glioma Precision MedicineMaria Guarnaccia, Valentina La Cognata, Giulia Gentile, et al.Genomics|February 25, 2014
Is this the real time for genomics?Maria Guarnaccia, Giulia Gentile, Enrico Alessi, et al.Journal of Personalized Medicine|May 28, 2022
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative DiseasesGiulia Gentile, Giovanna Morello, Valentina La Cognata, et al.Pageof 15